The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term survival adjusted for treatment crossover in patients (pts) with myelofibrosis (MF) treated with momelotinib (MMB) vs danazol (DAN) in the MOMENTUM trial.
 
Vikas Gupta
Stock and Other Ownership Interests - Syndax
Honoraria - Abbvie; Bristol-Myers Squibb/Celgene; CTI biophara; GlaxoSmithKline; Incyte; Novartis; Pfizer
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; CTI BioPharma Corp; GlaxoSmithKline; Incyte; Novartis
Research Funding - Abbvie (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patent on MPN24 a gene signature to predict outcome of Myelofibrosis (Inst)
 
Aaron Thomas Gerds
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; CTI; GlaxoSmithKline/Sierra Oncology; Imago Pharma; Kartos Therapeutics; MorphoSys; Pharmaessentia; Rain Therapeutics
Research Funding - Celgene; CTI; Gilead Sciences; Incyte; Pfizer; Roche/Genentech
 
Alessandro Vannucchi
Honoraria - Abbvie; AOP Orphan Pharmaceuticals; Bristol-Myers Squibb; GlaxoSmithKline; Incyte; Novartis; Roche
Speakers' Bureau - Abbvie; AOP Orphan Pharmaceuticals; Bristol-Myers Squibb; GlaxoSmithKline; Incyte; Novartis; Roche
 
Jean-Jacques Kiladjian
Consulting or Advisory Role - Abbvie; AOP Orphan Pharmaceuticals; BMS; GlaxoSmithKline; Incyte; Novartis; Pharmaessentia
 
Claire Harrison
Honoraria - Abbvie; CTI BioPharma Corp; Geron; GlaxoSmithKline (Inst); Janssen; Novartis
Consulting or Advisory Role - AOP Orphan Pharmaceuticals; BMS; Constellation Pharmaceuticals; CTI; Galecto; Geron; Incyte; Janssen; Keros Therapeutics; MorphoSys; Novartis; Roche
Speakers' Bureau - Abbvie; Bristol-Myers Squibb; CTI BioPharma Corp; Geron; GlaxoSmithKline; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Constellation Pharmaceuticals (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Alisa Urbano
Employment - GlaxoSmithKline
 
Jireh Huang
Employment - GlaxoSmithKline
Other Relationship - WuXi Biologics (I)
 
Catherine Elizabeth Ellis
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Ruben A. Mesa
Consulting or Advisory Role - Constellation Pharmaceuticals; La Jolla Pharma; Novartis; Sierra Oncology
Research Funding - Abbvie (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); CTI (Inst); Genentech (Inst); Incyte (Inst); Mays Cancer Center (Inst); NCI (Inst); Promedior (Inst); Samus (Inst)